Autologous Cultured Cell
- Name
- Autologous Cultured Cell
- Accession Number
- DBCAT003594
- Description
Not Available
- Drugs
Drug Drug Description Autologous cultured chondrocytes A cell therapy used to treat damage to cartilage in the knees. Azficel-T A medication composed of fibroblasts used to treat moderate to severe nasolabial wrinkles. Betibeglogene autotemcel A hematopoietic stem cell-based gene therapy used in the treatment of β-thalassemia in adult and pediatric patients who require regular red blood cell transfusions. Atidarsagene autotemcel A gene therapy comprising autologous CD34+ enriched stem cells encoding the human arylsulfatase A (ARSA) gene used to treat metachromatic leukodystrophy (MLD). Exagamglogene autotemcel An autologous CRISPR-Cas9 modified hematopoietic stem cell therapy for the treatment of patients with sickle cell disease and recurrent vaso-occlusive crises. Lovotibeglogene autotemcel An autologous CD34+ cell therapy used to treat sickle cell disease by providing a functional copy of the beta-globin gene - Drugs & Drug Targets
Drug Target Type Betibeglogene autotemcel Alpha globin target Atidarsagene autotemcel Human Arylsulfatase A mRNA target Lovotibeglogene autotemcel Hemoglobin subunit beta target